{"name":"Arch Oncology","slug":"arch-oncology","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQay0tWXhWdEgyZkx5eGxJUXpfeDZLeXJ4bkRKeEY4ekRmLV93OXRpQU94elJyMC1KcFpiaUtyLU8zbDFnMHgzcFc5cVJrdTZKejRDclo5UmR1S3Bla1RxUkNyYjd5LU1kUnBwdFZnV1RHOFF5emVjLXR2ZzFxbVpIQUplU010UGV6R3c?oc=5","date":"2026-03-19","type":"regulatory","source":"Oncology Pipeline","summary":"AACR 2026 – conjugates remain centre stage | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"AACR 2026 – conjugates remain centre stage | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNeTM4SFlmM1dQdnBHcWF5U2R3bGM1MHhEajZ4S0pndWZ4SERoWTVrSDN1dlYwZmFQMFAwSkhzeG1FZnpCRThyU2dFMDRidVBsN1gtSlNlV012NE44bndfd0JNRDkzeDlWeTJXU1pXXzJ4ZW5haU1LUnpZYklPR3MtdGltT3A5aGVnVGg0Qkg0aUEtZ0puRmxwNkQtQQ?oc=5","date":"2026-02-04","type":"pipeline","source":"The Pharma Letter","summary":"Third Arc Bio closes $52 million Series A extension - The Pharma Letter","headline":"Third Arc Bio closes $52 million Series A extension","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxPZ1AxYVlaeDNVcEQxaFRfaVVhTV9hUHc2VDB0aEY2RnA4QzE1eENRZGZJUXdaZUZvVFl1Ym5NbHhlcEt6UDMybTBzemY0SUF1OVl4NzBhRkVRTEJEc1d3U2JDZFpkMHNPTjVxN1FLOEZzSXBaeDhDUHM1anVLajhjQ0IwX1RqTnFVRktDck9aalhGVHZ3TVNkNzRrX1F6NUFDN0Z6d1JDaWpSenJkR1ZIUzluRndqbUpFMWRlV2I1MFRiQVRVbVhFUlNKM1l6aHpibWJ6TXIyXy1YSjlxY0FuNlR4bTBsejNURUpZXw?oc=5","date":"2026-01-30","type":"pipeline","source":"Business Wire","summary":"Oncology Imaging AI Strategy Report 2025-2032: Pathways, Platforms & Playbooks - ResearchAndMarkets.com - Business Wire","headline":"Oncology Imaging AI Strategy Report 2025-2032: Pathways, Platforms & Playbooks - ResearchAndMarkets.com","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQRElDcXo3VjNjRlNRTTVrTkpLZm11WWpQcGxoOFpiREo4V0JmZk5lS18xU080OGVXcWhOajhGLWhSMHItTkw4WmZjNFB5WkZ5d0tRZkxRTFktTVhVVTRCTlE4OWM3LVFJcDZ2cHVrbnZkak1PbjRkMHhlVlAtcHVaSVNEVzJaeTlZeC1uUWh3eUR6cy0xelEtVnRsN0h2YkNvNXZxOTFR?oc=5","date":"2026-01-08","type":"pipeline","source":"Fierce Biotech","summary":"Parabilis rockets ahead with $305M series F to 'upend the status quo' with tumor drug - Fierce Biotech","headline":"Parabilis rockets ahead with $305M series F to 'upend the status quo' with tumor drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOQkZRdEIybkRBQ0JHcWlhb010bjVGV3JndF9aWkJvUWNWdWZ1OHBJc0gxdFR5MHJTdjFfdERLT0hUUGIxMTFlLUhvNzJVVVJhMGVUaVJhNU5WNWNvREtBaFlqd0E2NlRjMk9FbEpNLV83Y0hUenNscTFUMmpTWm13bUdvNTgxQmpVcjRTZkpwUndrZnExNXBWUkpHd05fZDZFQ0dJNXhvd3R3SFdpOGJNNV9ON3g2ZVcwOHNV?oc=5","date":"2025-09-03","type":"pipeline","source":"Fierce Biotech","summary":"Treeline reaps $200M series A extension, plucks first 3 clinical candidates - Fierce Biotech","headline":"Treeline reaps $200M series A extension, plucks first 3 clinical candidates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9MWk5nSU1CUUlSOXhFYXh1ZFBaVHZVZXVqenl6NWUyQkdjVmRzNjBnVmpXUE9lMGNFODdUS2RfZFY3SzM3SnM0THBiQ1pVVnpTX0g4?oc=5","date":"2025-09-03","type":"pipeline","source":"FirstWord Pharma","summary":"With another $200M in hand, Treeline moves trio of cancer drugs into clinic - FirstWord Pharma","headline":"With another $200M in hand, Treeline moves trio of cancer drugs into clinic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQa3pqMEFQdGxBRmJ1eEUtUmh6cHRjTG1wa0RWRUk3OHU5ZjUwM1FVUVRYS2lsVWdJc1NNTnZRNnBiRW5Tb1g1YmRkYmVBWDF3b2txa2FlVHYyTnFZb2xJXzRiVHJUV0E4YUJPWDJ1U1hsSzRWcEdSZi1ndV9QZHdybUVCTUxRSnVLczFzSUd2dHh2dS1DTXFfRXZCXzVFdDVT?oc=5","date":"2025-07-23","type":"pipeline","source":"BioPharma Dive","summary":"Dispatch emerges with $216M and plans for a ‘universal’ solid tumor therapy - BioPharma Dive","headline":"Dispatch emerges with $216M and plans for a ‘universal’ solid tumor therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTE1vVGg3Ni0zdHk1NG8xYmJxcWp6b2ZUQWZ4WGpRVjEtVF9jX0F0LV9PTVBhV2FlY0YwZ0pDVUlXTDdPV1Q1VXc0QWtoak1WV1RPNG96b0FlR2lkUQ?oc=5","date":"2025-07-21","type":"pipeline","source":"ARC Group","summary":"China Innovative Pharma Going Global - ARC Group","headline":"China Innovative Pharma Going Global","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxPOURmU1lfaUJHZ0FmM0hEeWNoSW5PNlRaZ21nWkFialNhNmFjRW5DdmVNT0FMb21zY3hfbjhHNEZJV1RfZGxxTk1GZ0VOdDFBZ2JzRVRSNjRsN05mLVQ5Ym12QjJ2YmRkVVVza0RoSTB5MkROYndNekZtTEd3VkZ0aGFnZDJ3TXBlTW5MemdkanVXNGZpWkpRTlBjcnBoWjNqNWYxY2JCRDduZUpMcHdoeXI1SEJtYU45V0JxdVRud3AzSzA2QUs4RXdWamp6T3A4SlNMbm1PY0JCZGstTG5MVXhhS1ZVNnM5MzRrdUpJcUpmOXJ4TldsaUVVWUQzcGdvb21nb1BsTHY?oc=5","date":"2025-05-22","type":"pipeline","source":"PR Newswire","summary":"Astellas and Pfizer's XTANDI™ (enzalutamide) Shows Long-Term Overall Survival in Metastatic Hormone-Sensitive Prostate Cancer - PR Newswire","headline":"Astellas and Pfizer's XTANDI™ (enzalutamide) Shows Long-Term Overall Survival in Metastatic Hormone-Sensitive Prostate C","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOREZmV1ZuYmYxdng4UHRyTjdsdGxNX1g0N1N6MFdlX01za2Vxa0ppbFlCMWVmaW9YNGhiV242NWNWUnZPSU42WWpwV2otU0lDZHBCd2owd3lIWWVqZVFLSExyYm9iVWY0VHpQQ05PSjFSNHRSQTVCbzBzSXl2Q2Q5QXBGYnpuTUhZc0c0SkYxNmFfNnJYTE92dHhWOA?oc=5","date":"2023-01-13","type":"trial","source":"endpoints.news","summary":"Scoop: Roche-backed startup gives up on CD47, lays off all employees - endpoints.news","headline":"Scoop: Roche-backed startup gives up on CD47, lays off all employees","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPN1ROOGVySlI5dm05QzNtd0xpUEUxWXFMM2F1RVd1ZWxqanE1a2xNYUx3QlZMVTNMeEtyZlM4c2JvVDU3Q0hfVHpXVTU2OXViZnRRTjE1ZmUzYVZWTHNpSmMxSTlOblNWd0VxamZ0YzNTUG1IeWVVR3d1c2R3Z0xMSnc0MVdUVHkybFI0d2pvcnM3VFphQW1nRktPQU9nRVRjVW5uclRuTTExcWJmRHBiNQ?oc=5","date":"2021-04-27","type":"pipeline","source":"MedCity News","summary":"Arch Oncology adds $105M for better way to get immune cells to gobble up tumors - MedCity News","headline":"Arch Oncology adds $105M for better way to get immune cells to gobble up tumors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNT3RIcUd3RlhNaWNycUN5TXV6VVd3aG9kV2hlWEY5dFdXUmFfTWk5c05IV09aUHJqNXBrMFdrQ1NZUlJfeUdNU0g5YUczY0plUmtoUTMtY0VnOUQxdmNGZW14ZkdnVFdySUM0UnhrYTJaV0hsZnBGMDMtVFctM3BQZVJYdmtzblRKRVVCM29sTkRWRjZwSVZacmpjOEExSWlkSmhv?oc=5","date":"2021-04-07","type":"pipeline","source":"The Business Journals","summary":"St. Louis biotech startup Arch Oncology names new CEO - The Business Journals","headline":"St. Louis biotech startup Arch Oncology names new CEO","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}